ArticleBMC ophthalmology2025
Visual efficacy after implantation of monofocal intraocular lens on one eye and higher-order aspheric IOL on the other eye.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposeTo compare visual and refractive outcomes and patient satisfaction results after binocular cataract surgery with implantation of both TECNIS Eyhance ICB00 and TECNIS ZCB00 intraocular lenses in the same patient.
methodsOne hundred twelve eyes from 56 patients who underwent intraocular lens implantation with Eyhance ICB00 and ZCB00 in the same patient were retrospectively enrolled. Pre-operative and post- operative uncorrected and corrected near (UNVA, CNVA), intermediate (UIVA, CIVA), distant (UDVA, CDVA) visual acuity, and depth of focus were analyzed. Satisfaction surveys were evaluated after cataract surgery.
resultsThere was no significant difference in the preoperative values between the Eyhance ICB00 and ZCB00 groups. At two months postoperatively, UNVA of the ZCB00 group (0.02 ± 0.03 logMAR) was significantly better than that of the Eyhance ICB00 group (0.05 ± 0.05) (P < 0.05). At one week, one month, and two months postoperatively, the UIVA of the Eyhance ICB00 was significantly better than that of the ZCB00 group (P < 0.05). At two months postoperatively, the UNVA of the Eyhance ICB00 was significantly better than that of the ZCB00 group (P < 0.05). In the satisfaction survey, daily activities were not limited by their vision or glare in both groups.
conclusionInserting a high-aberration aspheric intraocular lens(IOL) in one eye rather than inserting a monofocal IOL in both eyes is better for improving distance, intermediate, and near vision. Furthermore, patients who have Eyhance ICB00 in one eye and a monofocal IOL in the other do not experience any difficulty in their daily lives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.